Skip to main content
Top
Published in: BMC Medical Research Methodology 1/2018

Open Access 01-12-2018 | Research article

Which ICD-9-CM codes should be used for bronchiolitis research?

Authors: Paul Walsh, Stephen J. Rothenberg

Published in: BMC Medical Research Methodology | Issue 1/2018

Login to get access

Abstract

Background

Bronchiolitis is a common respiratory disorder in children. Although there are specific ICD-9-CM diagnosis codes for bronchiolitis, the illness is often coded using broader diagnosis codes. This creates the potential for subject misclassification if researchers rely on specific diagnosis codes when assembling retrospective cohorts. Here we challenge the common research practice of relying on specific diagnosis codes for bronchiolitis.

Methods

We examined the use of diagnosis codes for the first episode of bronchiolitis, bronchitis, acute asthma, and bronchospasm and wheezing, in children younger than six and 24 months in the State of California Medic-Aid database. We categorized codes as narrow or broad diagnosis codes. We compared patient, geographic, and temporal characteristics of the different diagnoses codes.

Results

We identified visits from 48,732 children for first episode of wheezing illness. We retained 48,269 who had the diagnosis codes and data of interest. Diagnosis codes for acute asthma were widely used, even in children younger than six months in whom a diagnosis code for bronchiolitis would have been anticipated. The temporal pattern was similar across all diagnoses. Antipyretics were prescribed more often in those with diagnosis codes for bronchiolitis and bronchitis. Other statistically significant differences were too small to usefully distinguish the groups. There was substantial geographic variability in the diagnosis codes selected.

Conclusion

Users of Medic-Aid administrative data should generally favor broad rather than narrow definitions of bronchiolitis and should perform sensitivity analysis comparing broad and narrow definitions.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hasegawa K, Tsugawa Y, Brown DF, Mansbach JM, Camargo CA. Trends in bronchiolitis hospitalizations in the United States, 2000-2009. Pediatrics. 2013;132(1):28–36.CrossRef Hasegawa K, Tsugawa Y, Brown DF, Mansbach JM, Camargo CA. Trends in bronchiolitis hospitalizations in the United States, 2000-2009. Pediatrics. 2013;132(1):28–36.CrossRef
2.
3.
go back to reference McConnochie KM. Bronchiolitis. What’s in the name? Am J Dis Child. 1983;137(1):11–3.CrossRef McConnochie KM. Bronchiolitis. What’s in the name? Am J Dis Child. 1983;137(1):11–3.CrossRef
4.
go back to reference McIntosh K. Bronchiolitis and asthma: possible common pathogenetic pathways. J Allergy Clin Immunol. 1976;57(6):595–604.CrossRef McIntosh K. Bronchiolitis and asthma: possible common pathogenetic pathways. J Allergy Clin Immunol. 1976;57(6):595–604.CrossRef
5.
go back to reference Education NA, Program aP, Panel E. Guidelines for the diagnosis and management of asthma. In: National asthma education and prevention program expert panel Report 3. Bethesda, MD: United States Department of Health and Human Services, National Institutes for Health, and the National Heart Lung and Blood Institute; 2007. Education NA, Program aP, Panel E. Guidelines for the diagnosis and management of asthma. In: National asthma education and prevention program expert panel Report 3. Bethesda, MD: United States Department of Health and Human Services, National Institutes for Health, and the National Heart Lung and Blood Institute; 2007.
6.
go back to reference Pelletier AJ, Mansbach JM, Camargo CA Jr. Direct medical costs of bronchiolitis hospitalizations in the United States. Pediatrics. 2006;118(6):2418–23.CrossRef Pelletier AJ, Mansbach JM, Camargo CA Jr. Direct medical costs of bronchiolitis hospitalizations in the United States. Pediatrics. 2006;118(6):2418–23.CrossRef
7.
go back to reference Mansbach JM, Pelletier AJ, Camargo CA Jr. US outpatient office visits for bronchiolitis, 1993-2004. Ambul Pediatr. 2007;7(4):304–7.CrossRef Mansbach JM, Pelletier AJ, Camargo CA Jr. US outpatient office visits for bronchiolitis, 1993-2004. Ambul Pediatr. 2007;7(4):304–7.CrossRef
8.
go back to reference Plint AC, Johnson DW, Wiebe N, Bulloch B, Pusic M, Joubert G, Pianosi P, Turner T, Thompson G, Klassen TP. Practice variation among pediatric emergency departments in the treatment of bronchiolitis. Acad Emerg Med. 2004;11(4):353–60.CrossRef Plint AC, Johnson DW, Wiebe N, Bulloch B, Pusic M, Joubert G, Pianosi P, Turner T, Thompson G, Klassen TP. Practice variation among pediatric emergency departments in the treatment of bronchiolitis. Acad Emerg Med. 2004;11(4):353–60.CrossRef
9.
go back to reference Fleming DM. Weekly returns service of the Royal College of general practitioners. Commun Dis Public Health. 1999;2(2):96–100.PubMed Fleming DM. Weekly returns service of the Royal College of general practitioners. Commun Dis Public Health. 1999;2(2):96–100.PubMed
10.
go back to reference Pisati M. Simple thematic mapping. Stata J. 2004;4(4):361–78. Pisati M. Simple thematic mapping. Stata J. 2004;4(4):361–78.
11.
go back to reference Walsh P, Rothenberg SJ, O’Doherty S, Hoey H, Healy R. A validated clinical model to predict the need for admission and length of stay in children with acute bronchiolitis. Eur J Emerg Med. 2004;11(5):265–72.CrossRef Walsh P, Rothenberg SJ, O’Doherty S, Hoey H, Healy R. A validated clinical model to predict the need for admission and length of stay in children with acute bronchiolitis. Eur J Emerg Med. 2004;11(5):265–72.CrossRef
12.
go back to reference Chee C, Walsh P, Kuan S, Cabangangan J, Azimian K, Dong C, Tobias J, Rothenberg SJ. Emergency department septic screening in respiratory syncytial virus (RSV) and non-RSV bronchiolitis. West J Emerg Med. 2010;11(1):60–7.PubMedPubMedCentral Chee C, Walsh P, Kuan S, Cabangangan J, Azimian K, Dong C, Tobias J, Rothenberg SJ. Emergency department septic screening in respiratory syncytial virus (RSV) and non-RSV bronchiolitis. West J Emerg Med. 2010;11(1):60–7.PubMedPubMedCentral
13.
go back to reference Ecochard-Dugelay E, Beliah M, Perreaux F, de Laveaucoupet J, Bouyer J, Epaud R, Labrune P, Ducou-Lepointe H, Gajdos V. Clinical predictors of radiographic abnormalities among infants with bronchiolitis in a paediatric emergency department. BMC Pediatr. 2014;14:143.CrossRef Ecochard-Dugelay E, Beliah M, Perreaux F, de Laveaucoupet J, Bouyer J, Epaud R, Labrune P, Ducou-Lepointe H, Gajdos V. Clinical predictors of radiographic abnormalities among infants with bronchiolitis in a paediatric emergency department. BMC Pediatr. 2014;14:143.CrossRef
14.
go back to reference Corneli HM, Zorc JJ, Mahajan P, Shaw KN, Holubkov R, Reeves SD, Ruddy RM, Malik B, Nelson KA, Bregstein JS. A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis. New Engl J Med. 2007;357(4):331.CrossRef Corneli HM, Zorc JJ, Mahajan P, Shaw KN, Holubkov R, Reeves SD, Ruddy RM, Malik B, Nelson KA, Bregstein JS. A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis. New Engl J Med. 2007;357(4):331.CrossRef
15.
go back to reference Plint AC, Johnson DW, Patel H, Wiebe N, Correll R, Brant R, Mitton C, Gouin S, Bhatt M, Joubert G. Epinephrine and dexamethasone in children with bronchiolitis. New Engl J Med. 2009;360(20):2079–89.CrossRef Plint AC, Johnson DW, Patel H, Wiebe N, Correll R, Brant R, Mitton C, Gouin S, Bhatt M, Joubert G. Epinephrine and dexamethasone in children with bronchiolitis. New Engl J Med. 2009;360(20):2079–89.CrossRef
16.
go back to reference Liebelt EL, Qi K, Harvey K. Diagnostic testing for serious bacterial infections in infants aged 90 days or younger with bronchiolitis. Arch Pediatr Adolesc Med. 1999;153(5):525–30.CrossRef Liebelt EL, Qi K, Harvey K. Diagnostic testing for serious bacterial infections in infants aged 90 days or younger with bronchiolitis. Arch Pediatr Adolesc Med. 1999;153(5):525–30.CrossRef
17.
go back to reference Walsh P, Gonzales A, Satar A, Rothenberg SJ. The interrater reliability of a validated bronchiolitis severity assessment tool. Pediatr Emerg Care. 2006;22(5):316.CrossRef Walsh P, Gonzales A, Satar A, Rothenberg SJ. The interrater reliability of a validated bronchiolitis severity assessment tool. Pediatr Emerg Care. 2006;22(5):316.CrossRef
18.
go back to reference A plea to abandon asthma as a disease concept. Lancet. 2006;368(9537):705. A plea to abandon asthma as a disease concept. Lancet. 2006;368(9537):705.
19.
go back to reference Leonard CE, Brensinger CM, Nam YH, Bilker WB, Barosso GM, Mangaali MJ, Hennessy S. The quality of Medicaid and Medicare data obtained from CMS and its contractors: implications for pharmacoepidemiology. BMC Health Serv Res. 2017;17(1):304.CrossRef Leonard CE, Brensinger CM, Nam YH, Bilker WB, Barosso GM, Mangaali MJ, Hennessy S. The quality of Medicaid and Medicare data obtained from CMS and its contractors: implications for pharmacoepidemiology. BMC Health Serv Res. 2017;17(1):304.CrossRef
20.
go back to reference Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE, Gadomski AM, Johnson DW, Light MJ, Maraqa NF, Mendonca EA, et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics. 2014;134(5):e1474–502.CrossRef Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE, Gadomski AM, Johnson DW, Light MJ, Maraqa NF, Mendonca EA, et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics. 2014;134(5):e1474–502.CrossRef
21.
go back to reference Walsh P, Rothenberg SJ. American Academy of Pediatrics 2014 bronchiolitis guidelines: bonfire of the evidence. West J Emerg Med. 2015;16(1):85–8.CrossRef Walsh P, Rothenberg SJ. American Academy of Pediatrics 2014 bronchiolitis guidelines: bonfire of the evidence. West J Emerg Med. 2015;16(1):85–8.CrossRef
22.
go back to reference Walsh P, Caldwell J, McQuillan KK, Friese S, Robbins D, Rothenberg SJ. Comparison of nebulized epinephrine to albuterol in bronchiolitis. AcadEmerg Med. 2008;15(4):305–13. Walsh P, Caldwell J, McQuillan KK, Friese S, Robbins D, Rothenberg SJ. Comparison of nebulized epinephrine to albuterol in bronchiolitis. AcadEmerg Med. 2008;15(4):305–13.
23.
go back to reference Ronald LA, Ling DI, FitzGerald JM, Schwartzman K, Bartlett-Esquilant G, Boivin JF, Benedetti A, Menzies D. Validated methods for identifying tuberculosis patients in health administrative databases: systematic review. Int J Tuberc Lung Dis. 2017;21(5):517–22.CrossRef Ronald LA, Ling DI, FitzGerald JM, Schwartzman K, Bartlett-Esquilant G, Boivin JF, Benedetti A, Menzies D. Validated methods for identifying tuberculosis patients in health administrative databases: systematic review. Int J Tuberc Lung Dis. 2017;21(5):517–22.CrossRef
24.
go back to reference Huang H, Turner M, Raju S, Reich J, Leatherman S, Armstrong K, Woods P, Ferguson RE, Fiore LD, Lederle FA. Identification of acute decompensated heart failure hospitalizations using administrative data. Am J Cardiol. 2017;119(11):1791–6.CrossRef Huang H, Turner M, Raju S, Reich J, Leatherman S, Armstrong K, Woods P, Ferguson RE, Fiore LD, Lederle FA. Identification of acute decompensated heart failure hospitalizations using administrative data. Am J Cardiol. 2017;119(11):1791–6.CrossRef
25.
go back to reference Sommers BD. From Medicaid to uninsured: drop-out among children in public insurance programs. Health Serv Res. 2005;40(1):59–78.CrossRef Sommers BD. From Medicaid to uninsured: drop-out among children in public insurance programs. Health Serv Res. 2005;40(1):59–78.CrossRef
Metadata
Title
Which ICD-9-CM codes should be used for bronchiolitis research?
Authors
Paul Walsh
Stephen J. Rothenberg
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2018
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/s12874-018-0589-4

Other articles of this Issue 1/2018

BMC Medical Research Methodology 1/2018 Go to the issue